Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.61 -0.03 (-1.83%)
At close: Sep 29, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Total Current Liabilities (2017 - 2026)

Updated

Chemomab Therapeutics' Total Current Liabilities was $1.55 million in Q2 2026, up 8.6% from $1.43 million a year earlier and up 39.5% from the prior quarter.

Analysis

Chemomab Therapeutics (CMMB) Total Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Chemomab Therapeutics came in at $1.48 million, down 54.1% from FY2024.

  • Total Current Liabilities has now declined for three consecutive years, though with a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $3.22 million in FY2024 (-33.5%), $4.84 million in FY2023 (-28.3%), $6.75 million in FY2022 (+154.7%) and $2.65 million in FY2021 (+101.4%).
  • The Q2 2026 figure marks the highest quarterly Total Current Liabilities since Q1 2025.
  • Compared with a year earlier, Total Current Liabilities was higher in 1 of the last eight quarters, with an average decline of 42.3%.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q3 2022 (growth of 236.0%); the worst was Q3 2025 (a decline of 73.9%).
  • Per Business Quant data, CMMB's Total Current Liabilities in the three quarters before Q2 2026 was $1.11 million (Q1 2026), $1.48 million (Q4 2025) and $1.14 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Chemomab Therapeutics 11.80 Mn 11.80 Mn - 1.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.55 Mn
Mar 31, 2026 1.11 Mn
Dec 31, 2025 1.48 Mn
Sep 30, 2025 1.14 Mn
Jun 30, 2025 1.43 Mn
Mar 31, 2025 2.25 Mn
Dec 31, 2024 3.22 Mn
Sep 30, 2024 4.35 Mn
Jun 30, 2024 4.31 Mn
Mar 31, 2024 4.40 Mn
Dec 31, 2023 4.84 Mn
Sep 30, 2023 5.37 Mn
Jun 30, 2023 6.83 Mn
Mar 31, 2023 7.00 Mn
Dec 31, 2022 6.75 Mn
Sep 30, 2022 5.48 Mn
Jun 30, 2022 4.39 Mn
Mar 31, 2022 3.52 Mn
Dec 31, 2021 2.65 Mn
Sep 30, 2021 1.63 Mn
API Access

Chemomab Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CMMB&period=max&api_key=YOUR_API_KEY